Lundbeck's new TV and digital campaign for its migraine med Vyepti focuses on daily patient challenges.
Lundbeck encourages migraine patients to ‘Say Yep’ to its IV-infused med in latest campaign
Lundbeck is taking a new tack in its migraine marketing for Vyepti, the only IV-infused option in the crowded market. The campaign, launched this week …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
